Fig. 2From: Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective studyThe proportions and numbers of patients achieving clinical efficacy during follow-up. *p < 0.05; **p < 0.01Back to article page